Closed Solicitation · DEPARTMENT OF HEALTH AND HUMAN SERVICES

    RAPID GENE SYNTHESIS FOR CANDIDATE VACCINE VIRUSES (CVV) DEVELOPMENT

    Sol. 2023-73419PresolicitationATLANTA, GA
    Closed
    STATUS
    Closed
    POSTED
    May 8, 2023
    Publication date
    NAICS CODE
    541715
    Primary industry classification
    PSC CODE
    Product & service classification

    AI Summary

    The CDC is seeking proposals for the rapid gene synthesis of Candidate Vaccine Viruses (CVVs) to support the development of vaccines against circulating and novel influenza strains. This presolicitation invites qualified vendors to provide their expertise in biotechnology services for this critical health initiative.

    Contract details

    Solicitation No.
    2023-73419
    Notice Type
    Presolicitation
    Posted Date
    May 8, 2023
    Response Deadline
    NAICS Code
    541715AI guide
    State
    GA
    ZIP Code
    30333
    AI Product/Service
    service

    Description

    CDC Influenza’s Division is responsible for the development of Candidate Vaccine Viruses based on circulating and novel influenza strains. Candidate Vaccine Viruses (CVVs) are reassortant viruses which are used as the starting materials for

    Key dates

    1. May 8, 2023Posted Date

    AI search tags

    Frequently asked questions

    RAPID GENE SYNTHESIS FOR CANDIDATE VACCINE VIRUSES (CVV) DEVELOPMENT is a federal acquisition solicitation issued by DEPARTMENT OF HEALTH AND HUMAN SERVICES. Review the full description, attachments, and submission requirements on SamSearch before the response deadline.

    SamSearch Platform

    Stop searching. Start winning.

    AI-powered intelligence for the right opportunities, the right leads, and the right time.